Engineers Gate Manager’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Engineers Gate Manager’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-431,939	Closed	-$1.73M	–	2111
2019 Q4	$1.73M	Buy	431,939 +281,953	+188%	+$1.32M	0.08%	401
2019 Q3	$735K	Buy	+149,986	New	+$839K	0.04%	645
2019 Q2	–	Sell	-199,869	Closed	-$1.16M	–	1479
2019 Q1	$1.16M	Buy	199,869 +123,917	+163%	+$1.28M	0.07%	404
2018 Q4	$1.02M	Buy	75,952 +64,747	+578%	+$1.09M	0.08%	349
2018 Q3	$217K	Sell	11,205 -62,514	-85%	-$1.33M	0.02%	718
2018 Q2	$1.88M	Buy	+73,719	New	+$1.72M	0.15%	230
2017 Q4	–	Sell	-67,805	Closed	-$1.4M	–	923
2017 Q3	$1.4M	Buy	67,805 +21,059	+45%	+$356K	0.12%	344
2017 Q2	$692K	Buy	+46,746	New	+$779K	0.06%	446
2016 Q2	–	Sell	-9,357	Closed	-$256K	–	886
2016 Q1	$256K	Buy	+9,357	New	+$276K	0.02%	587

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Engineers Gate Manager's DPLO Position: Q1 2020 in Review

Engineers Gate Manager sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 431,939 shares — an estimated $1.73M sold.

Engineers Gate Manager first reported a position in DPLO in Q1 2016 and held it in 9 quarters. The position peaked at $1.88M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Engineers Gate Manager reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Engineers Gate Manager sold 431,939 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.73M.
Engineers Gate Manager first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 9 quarters.
Engineers Gate Manager's DIPLOMAT PHARMACY, INC. position peaked at $1.88M in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Engineers Gate Manager's 13F filing for Q1 2020, filed 15 May 2020.